FDA updates labeling for NALBUPHINE HYDROCHLORIDE
Labeling changes approved for SOMERSET THERAPS LLC. Active ingredient: NALBUPHINE HYDROCHLORIDE. Decision date: 12/22/2025
Labeling changes approved for SOMERSET THERAPS LLC. Active ingredient: NALBUPHINE HYDROCHLORIDE. Decision date: 12/22/2025
There are no comments here yet...